Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Kwangsu Park

Assistant Professor

Keimyung University

South Korea

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in South Korea Professors in Biochemistry Biochemistry professors in South Korea

About

Dr. Kwangsu Park is an Assistant Professor at Keimyung University, South Korea. His research primarily focuses on targeted protein degradation, with significant contributions to the development of PROTAC technology and its application in treating neurodegenerative diseases such as Alzheimer’s. He has authored several recent articles that explore innovative strategies for targeting proteins associated with cancer and other pathologies.

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (4)

Hyun Jin Park

Assistant professor

Keimyung University

SOUTH KOREA

View details

Ping Dong

Research Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Donghyuk Shin

Assistant Professor

Yonsei University

SOUTH KOREA

View details

Mohanish Deshmukh

William R. Kenan, Jr. Distinguished Professor

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kwangsu Park

Research Interests

Make your next move.

Explore related searches

About

Articles (13)

Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy

Induced proximity for dephosphorylation

Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8

Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology

PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation

Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader

Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor

Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2

Discovery of the First-in-Class G9a/GLP PROTAC Degrader

Discovery of the First-in-Class G9a/GLP PROTAC Degrader

Discovery of a novel, highly potent VHL-recruiting EZH2 PROTAC degrader targeting MLL-r AML

Collaborators (4)

Hyun Jin Park

Ping Dong

Donghyuk Shin

Mohanish Deshmukh

Make your next move.